Paul K. Wotton
Director, ANTARES PHARMA, INC.
Companies
- VericelBoard member Jan 7, 2015 to now1
- ANTARES PHARMA, INC.Chief executive officer Oct 21, 2008 to Jun 2, 20142
- ANTARES PHARMA, INC.President Aug 7, 2008 to Jun 2, 20143
- ANTARES PHARMA, INC.Board member Jan 5, 2006 to Jun 2, 20144
- ANTARES PHARMA, INC.Chief operating officer Aug 7, 2008 to Aug 7, 20083
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
As of each latest filing. The line shows shares held over time.
Recent filings
- May 11, 2026Sold 7,500 shares at $32.64 of Vericel5
- May 11, 2026Sold 2,500 shares at $33.05 of Vericel5
- Apr 29, 2026Exercised options 3,200 shares of Vericel6
- Dec 3, 2025Sold 2,500 shares at $37.83 of Vericel7
- Dec 2, 2025Sold 2,500 shares at $37.97 of Vericel7
- Apr 30, 2025Exercised options 3,200 shares of Vericel8
- Dec 4, 2024Sold 2,600 shares at $58.72 of Vericel9
- May 1, 2024Exercised options 3,200 shares of Vericel10
- Dec 14, 2023Sold 5,000 shares at $37.31 of Vericel11
- Apr 27, 2023Exercised options 2,600 shares of Vericel12
- Apr 27, 2022Exercised options 2,600 shares of Vericel13
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARVericel, Board member
- 2
- 3SEC EDGARANTARES PHARMA, INC., President
- 4SEC EDGARANTARES PHARMA, INC., Board member
- 5
- 6SEC EDGARForm 4 filed May 1, 2026
- 7SEC EDGARForm 4 filed Dec 4, 2025
- 8SEC EDGARForm 4 filed May 2, 2025
- 9SEC EDGARForm 4 filed Dec 5, 2024
- 10SEC EDGARForm 4 filed May 3, 2024
- 11SEC EDGARForm 4 filed Dec 15, 2023
- 12SEC EDGARForm 4 filed Apr 28, 2023
- 13SEC EDGARForm 4 filed Apr 29, 2022